| 1 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 9.70335363 |
| 2 | tolerance induction (GO:0002507) | 9.44964025 |
| 3 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 9.14095104 |
| 4 | negative regulation of glycogen biosynthetic process (GO:0045719) | 8.98464915 |
| 5 | regulation of oxidative stress-induced neuron death (GO:1903203) | 8.97561256 |
| 6 | galactose catabolic process (GO:0019388) | 8.88680796 |
| 7 | N-terminal protein amino acid acetylation (GO:0006474) | 8.77871525 |
| 8 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 8.51090310 |
| 9 | regulation of energy homeostasis (GO:2000505) | 8.27983912 |
| 10 | negative regulation of muscle hypertrophy (GO:0014741) | 8.27092179 |
| 11 | interleukin-6-mediated signaling pathway (GO:0070102) | 8.21309363 |
| 12 | membrane tubulation (GO:0097320) | 8.14535624 |
| 13 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 7.87322032 |
| 14 | regulation of cellular respiration (GO:0043457) | 7.38778923 |
| 15 | negative regulation of glycogen metabolic process (GO:0070874) | 7.23637773 |
| 16 | protein localization to endosome (GO:0036010) | 7.13486766 |
| 17 | cellular response to interleukin-6 (GO:0071354) | 6.54656864 |
| 18 | ribosomal small subunit biogenesis (GO:0042274) | 6.45825238 |
| 19 | cysteine metabolic process (GO:0006534) | 6.04560966 |
| 20 | forebrain morphogenesis (GO:0048853) | 6.02919922 |
| 21 | sequestering of actin monomers (GO:0042989) | 5.90264176 |
| 22 | protein heterotetramerization (GO:0051290) | 5.62087605 |
| 23 | response to interleukin-6 (GO:0070741) | 5.31921752 |
| 24 | ubiquinone biosynthetic process (GO:0006744) | 5.22392137 |
| 25 | ribonucleoprotein complex biogenesis (GO:0022613) | 5.11962129 |
| 26 | response to nitrosative stress (GO:0051409) | 5.06354742 |
| 27 | viral transcription (GO:0019083) | 5.02915136 |
| 28 | galactose metabolic process (GO:0006012) | 5.01585534 |
| 29 | ribosome biogenesis (GO:0042254) | 4.99917925 |
| 30 | ubiquinone metabolic process (GO:0006743) | 4.89286453 |
| 31 | translational termination (GO:0006415) | 4.77664409 |
| 32 | spermatid nucleus differentiation (GO:0007289) | 4.67474427 |
| 33 | ribosomal large subunit biogenesis (GO:0042273) | 4.50420037 |
| 34 | quinone biosynthetic process (GO:1901663) | 4.37608770 |
| 35 | valine metabolic process (GO:0006573) | 4.17115269 |
| 36 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.15668736 |
| 37 | viral life cycle (GO:0019058) | 4.10248945 |
| 38 | otic vesicle formation (GO:0030916) | 4.06585124 |
| 39 | L-phenylalanine catabolic process (GO:0006559) | 4.03409815 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.03409815 |
| 41 | regulation of the force of heart contraction (GO:0002026) | 3.97598517 |
| 42 | N-terminal protein amino acid modification (GO:0031365) | 3.96289699 |
| 43 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.91513809 |
| 44 | cotranslational protein targeting to membrane (GO:0006613) | 3.90112410 |
| 45 | negative regulation of potassium ion transport (GO:0043267) | 3.89666071 |
| 46 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.88708259 |
| 47 | cellular response to nicotine (GO:0071316) | 3.84961421 |
| 48 | tyrosine metabolic process (GO:0006570) | 3.79833373 |
| 49 | protein targeting to ER (GO:0045047) | 3.78116352 |
| 50 | cellular protein complex disassembly (GO:0043624) | 3.76088648 |
| 51 | regulation of respiratory gaseous exchange (GO:0043576) | 3.73212330 |
| 52 | cell proliferation in forebrain (GO:0021846) | 3.66405220 |
| 53 | translational elongation (GO:0006414) | 3.65328301 |
| 54 | dendrite development (GO:0016358) | 3.63531429 |
| 55 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.59372155 |
| 56 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.57885177 |
| 57 | megakaryocyte development (GO:0035855) | 3.56647731 |
| 58 | regulation of hypersensitivity (GO:0002883) | 3.53474858 |
| 59 | protein localization to endoplasmic reticulum (GO:0070972) | 3.51282798 |
| 60 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.50678884 |
| 61 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.45941467 |
| 62 | cellular component biogenesis (GO:0044085) | 3.41758201 |
| 63 | vesicle fusion (GO:0006906) | 3.40622241 |
| 64 | regulation of proton transport (GO:0010155) | 3.40614970 |
| 65 | lymph node development (GO:0048535) | 3.35767645 |
| 66 | regulation of mitochondrial depolarization (GO:0051900) | 3.34416303 |
| 67 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.33052160 |
| 68 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.33052160 |
| 69 | L-phenylalanine metabolic process (GO:0006558) | 3.30953036 |
| 70 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.30953036 |
| 71 | positive regulation of T cell apoptotic process (GO:0070234) | 3.25506329 |
| 72 | protein complex disassembly (GO:0043241) | 3.25392234 |
| 73 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.22814423 |
| 74 | Peyers patch development (GO:0048541) | 3.22814423 |
| 75 | regulation of cardiac muscle hypertrophy (GO:0010611) | 3.17762678 |
| 76 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.17443003 |
| 77 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.17443003 |
| 78 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.17443003 |
| 79 | isoprenoid biosynthetic process (GO:0008299) | 3.09298215 |
| 80 | regulation of muscle hypertrophy (GO:0014743) | 3.07625758 |
| 81 | superoxide anion generation (GO:0042554) | 3.05391261 |
| 82 | response to insecticide (GO:0017085) | 3.05113585 |
| 83 | innate immune response in mucosa (GO:0002227) | 3.04839713 |
| 84 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.04786471 |
| 85 | maturation of 5.8S rRNA (GO:0000460) | 3.04588127 |
| 86 | endosome to pigment granule transport (GO:0043485) | 3.04240399 |
| 87 | endosome to melanosome transport (GO:0035646) | 3.04240399 |
| 88 | oligosaccharide biosynthetic process (GO:0009312) | 3.04050677 |
| 89 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.03414561 |
| 90 | positive regulation of positive chemotaxis (GO:0050927) | 3.03388832 |
| 91 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.02112301 |
| 92 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.00337403 |
| 93 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00018569 |
| 94 | mucosal immune response (GO:0002385) | 2.98971920 |
| 95 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.95813546 |
| 96 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.95813546 |
| 97 | regulation of positive chemotaxis (GO:0050926) | 2.94675506 |
| 98 | macromolecular complex disassembly (GO:0032984) | 2.93744806 |
| 99 | regulation of mesoderm development (GO:2000380) | 2.91714692 |
| 100 | ribosomal small subunit assembly (GO:0000028) | 2.90572532 |
ANP32C 
